Aortic Stenosis with Atrial Septal Defect
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease
Europace (2017) 0, 1–21 EHRA CONSENSUS DOCUMENT doi:10.1093/europace/eux240 Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardıaca y Electrofisiologıa (SOLEACE) Gregory Y. H. Lip1*, Jean Philippe Collet2, Raffaele de Caterina3, Laurent Fauchier4, Deirdre A. Lane5, Torben B. Larsen6, Francisco Marin7, Joao Morais8, Calambur Narasimhan9, Brian Olshansky10, Luc Pierard11, Tatjana Potpara12, Nizal Sarrafzadegan13, Karen Sliwa14, Gonzalo Varela15, Gemma Vilahur16, Thomas Weiss17, Giuseppe Boriani18 and Bianca Rocca19 Document Reviewers: Bulent Gorenek20 (Reviewer Coordinator), Irina Savelieva21, Christian Sticherling22, Gulmira Kudaiberdieva23, Tze-Fan Chao24, Francesco Violi25, Mohan Nair26, Leandro Zimerman27, Jonathan Piccini28, Robert Storey29, Sigrun Halvorsen30, Diana Gorog31, Andrea Rubboli32, Ashley Chin33 and Robert Scott-Millar34 * Corresponding author. Tel/fax: þ44 121 5075503. E-mail address: [email protected] Published on behalf of the European Society of Cardiology. All rights reserved. VC The Author 2017. For permissions, please email: [email protected]. 2 G.Y.H. Lip 1Institute of Cardiovascular Sciences, University of Birmingham and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Denmark (Chair, representing EHRA); 2Sorbonne Universite´ Paris 6, ACTION Study Group, Institut De Cardiologie, Groupe Hoˆpital Pitie´-Salpetrie`re (APHP), INSERM UMRS 1166, Paris, France; 3Institute of Cardiology, ‘G. -
Mitral Regurgitation Associated with Secundum Atrial Septal Defect
The THAI Journal of SURGERY 2010;31:120-124. Original Article Official Publication of the Royal College of Surgeons of Thailand Mitral Regurgitation Associated with Secundum Atrial Septal Defect Somchai Waikittipong, MD Department of Surgery, Yala Hospital, Yala, Thailand Abstract Introduction: Mitral regurgitation associated with secundum atrial septal defect is not uncommon. We reported our experiences and also reviewed its etiologies and managements in the literatures. Patients and Methods: Mitral regurgitation was found in 13% (12 patients) of all patients with secundum atrial septal defect (93 patients) who were operated on during 9-year period at Yala Hospital. The etiologies were as follows : rheumatic valve 3, prolapsed anterior leaflet 2, congenital abnormality 2, specific pathology complex 4, and chronic infective endocarditis 1. All patients underwent closure of secundum atrial septal defect with mitral valve repair. Results: There was one death and one serious post-operative complication. On follow-up, the echocardiograms showed no mitral regurgitation in 10 patients and mild mitral regurgitation in 1 patient. Conclusion: Mitral regurgitation associated with secundum atrial septal defect could exist as an co- existent lesion or as the result of hemodynamic change occurred in secundum atrial septal defect. Its recognisation is important and most of them could be repaired with satisfactory results. Key words: Mitral regurgitation, secundum atrial septal defect INTRODUCTION PATIENTS AND METHODS The association of a secundum atrial septal defect From January 2001 to July 2010, 12 patients with and mitral regurgitation is not uncommon. Reports secundum atrial septal defect associated with mitral have attributed mitral regurgitation in these patients regurgitation were operated. -
Avalus™ Pericardial Aortic Surgical Valve System
FACT SHEET Avalus™ Pericardial Aortic Surgical Valve System Aortic stenosis is a common heart problem caused by a narrowing of the heart’s aortic valve due to excessive calcium deposited on the valve leaflets. When the valve narrows, it does not open or close properly, making the heart work harder to pump blood throughout the body. Eventually, this causes the heart to weaken and function poorly, which may lead to heart failure and increased risk for sudden cardiac death. Disease The standard treatment for patients with aortic valve disease is surgical aortic valve Overview: replacement (SAVR). During this procedure, a surgeon will make an incision in the sternum to open the chest and expose the heart. The diseased native valve is then Aortic removed and a new artificial valve is inserted. Once in place, the device is sewn into Stenosis the aorta and takes over the original valve’s function to enable oxygen-rich blood to flow efficiently out of the heart. For patients that are unable to undergo surgical aortic valve replacement, or prefer a minimally-invasive therapy option, an alternative procedure to treat severe aortic stenosis is called transcatheter aortic valve replacement (TAVR). The Avalus Pericardial Aortic Surgical Valve System is a next- generation aortic surgical valve from Medtronic, offering advanced design concepts and unique features for the millions of patients with severe aortic stenosis who are candidates for open- heart surgery. The Avalus Surgical Valve The Avalus valve, made of bovine tissue, is also the only stented surgical aortic valve on the market that is MRI-safe (without restrictions) enabling patients with severe aortic stenosis who have the Avalus valve to undergo screening procedures for potential co-morbidities. -
Mitral Regurgitation Associated with Secundum Atrial Septal Defect
The THAI Journal of SURGERY 2010;31:120-124. Original Article Official Publication of the Royal College of Surgeons of Thailand Mitral Regurgitation Associated with Secundum Atrial Septal Defect Somchai Waikittipong, MD Department of Surgery, Yala Hospital, Yala, Thailand Abstract Introduction: Mitral regurgitation associated with secundum atrial septal defect is not uncommon. We reported our experiences and also reviewed its etiologies and managements in the literatures. Patients and Methods: Mitral regurgitation was found in 13% (12 patients) of all patients with secundum atrial septal defect (93 patients) who were operated on during 9-year period at Yala Hospital. The etiologies were as follows : rheumatic valve 3, prolapsed anterior leaflet 2, congenital abnormality 2, specific pathology complex 4, and chronic infective endocarditis 1. All patients underwent closure of secundum atrial septal defect with mitral valve repair. Results: There was one death and one serious post-operative complication. On follow-up, the echocardiograms showed no mitral regurgitation in 10 patients and mild mitral regurgitation in 1 patient. Conclusion: Mitral regurgitation associated with secundum atrial septal defect could exist as an co- existent lesion or as the result of hemodynamic change occurred in secundum atrial septal defect. Its recognisation is important and most of them could be repaired with satisfactory results. Key words: Mitral regurgitation, secundum atrial septal defect INTRODUCTION PATIENTS AND METHODS The association of a secundum atrial septal defect From January 2001 to July 2010, 12 patients with and mitral regurgitation is not uncommon. Reports secundum atrial septal defect associated with mitral have attributed mitral regurgitation in these patients regurgitation were operated. -
Atrial Arrythmia in Atrial Septal Defect Patient: a Case Report and Review of Literature
ACI (Acta Cardiologia Indonesiana) (Vol.4 No.2): 117-121 Atrial Arrythmia in Atrial Septal Defect Patient: A Case Report and Review of Literature Indah Paranita*, Lucia Kris Dinarti, Bambang Irawan Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada, Yogyakarta, Indonesia *Corresponding author : Indah Paranita, MD, - email: [email protected] Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada, Yogyakarta, Indonesia Jalan Farmako no1 Sekip Utara, Yogyakarta 55281 Manuscript submitted: April 8, 2018; Revised and accepted: August 18, 2018 ABSTRACT Atrial fibrillation (AF) and atrial flutter are the most common cardiac arrhythmias associated with atrial septal defects (ASD) in adult patients. The incidence could be as high as 52% in patients ages 60 years or more.Patient with congenital heart disease who developed atrial arrhythmias had a >50% increased stroke risk. Nevertheless, studies regarding the pathophysiological mechanism underlying the high incidence of atrial fibrillation in adult patients with ASD remain relatively few. We reported a female 46 years referred to Sardjito hospital with chest discomfort and palpitation. ECG showed atrial flutter, 90 beat per minute, incomplete RBBB, RAD and RVH. Transthoracal echocardiography shown ASD left to right shunt with diameter 1.2 -1.8 cm, LA, RA and RV dilatation, with normal systolic function. From right heart catetherization, the result is ASD High Flow Low Resistance, with pulmonary hypertension (mPAP 44 mmHg).The consequences of left to right shunt across an ASD is RV volume overload and pulmonary overcirculation. Atrial arrhytmia are a common result of long standing right side heart volume and pressure overload. -
Heart Failure in Aortic Stenosis — Improving Diagnosis and Treatment Michael R
The new england journal of medicine perspective Heart Failure in Aortic Stenosis — Improving Diagnosis and Treatment Michael R. Zile, M.D., and William H. Gaasch, M.D. The development of heart failure in patients with tional to the stroke volume divided by the square aortic stenosis is associated with a high mortality root of the pressure gradient. Therefore, if the stroke rate — unless aortic-valve replacement is per- volume declines, as it does in some patients with formed. There is an especially high risk of death aortic stenosis in whom heart failure has developed, among patients with aortic stenosis and a decreased there is a proportional decline in the pressure gra- ejection fraction. Before surgery is performed in dient. Under these low-flow conditions, the cal- such patients, initial management must include an culated effective aortic-valve area may indicate the evaluation of the severity of the stenotic lesion and presence of severe aortic stenosis, despite a low the functional state of the left ventricle; in addition, transvalvular pressure gradient. A mean pressure the heart failure must be treated and the patient’s gradient that is less than 30 mm Hg in a patient with condition stabilized. It is possible to pursue both what appears to be severe aortic stenosis (an aortic- of these goals simultaneously with echocardio- valve area of <1 cm2) indicates what is referred to as graphic techniques or cardiac catheterization tech- “low-gradient aortic stenosis.” niques, together with selected pharmacologic in- An example of a low pressure gradient in a pa- terventions. Proper evaluation and treatment require an un- derstanding of the pathophysiology of heart failure ABC in patients with aortic stenosis. -
Transcatheter Device Closure of Atrial Septal Defect in Dextrocardia with Situs Inversus Totalis
Case Report Nepalese Heart Journal 2019; Vol 16(1), 51-53 Transcatheter device closure of atrial septal defect in dextrocardia with situs inversus totalis Kiran Prasad Acharya1, Chandra Mani Adhikari1, Aarjan Khanal2, Sachin Dhungel1, Amrit Bogati1, Manish Shrestha3, Deewakar Sharma1 1 Department of Cardiology, Shahid Gangalal National Heart Centre, Kathmandu, Nepal 2 Department of Internal Medicine, Kathmandu Medical College, Kathmandu,Nepal 3 Department of Pediatric Cardiology, Shahid Gangalal National Heart Centre, Kathmandu, Nepal Corresponding Author: Chandra Mani Adhikari Department of Cardiology Shahid Gangalal National Heart Centre Kathmandu, Nepal Email: [email protected] Cite this article as: Acharya K P, Adhikari C M, Khanal A, et al. Transcatheter device closure of atrial septal defect in dextrocardia with situs inversus totalis. Nepalese Heart Journal 2019; Vol 16(1), 51-53 Received date: 17th February 2019 Accepted date: 16th April 2019 Abstract Only few cases of Device closure of atrial septal defect in dextrocardia with situs inversus totalis has been reported previously. We present a case of a 36 years old male, who had secundum type of atrial septal defect in dextrocardia with situs inversus totalis. ASD device closure was successfully done. However, we encountered few technical difficulties in this case which are discussed in this case review. Keywords: atrial septal defect; dextrocardia; transcatheter device closure, DOI: https://doi.org/10.3126/njh.v16i1.23901 Introduction There are only two case reported of closure of secundum An atrial septal defect (ASD) is an opening in the atrial ASD associated in patients with dextrocardia and situs inversus septum, excluding a patent foramen ovale.1 ASD is a common totalis. -
Accuracy of the Single Cycle Length Method for Calculation of Aortic Effective Orifice Area in Irregular Heart Rhythms
AORTIC STENOSIS Accuracy of the Single Cycle Length Method for Calculation of Aortic Effective Orifice Area in Irregular Heart Rhythms Kerry A. Esquitin, MD, Omar K. Khalique, MD, Qi Liu, MD, Susheel K. Kodali, MD, Leo Marcoff, MD, Tamim M. Nazif, MD, Isaac George, MD, Torsten P. Vahl, MD, Martin B. Leon, MD, and Rebecca T. Hahn, MD, New York, New York; and Morristown, New Jersey Introduction: In irregular heart rhythms, echocardiographic calculation of aortic effective orifice area (EOA) re- quires averaging measurements from multiple cardiac cycles. Whether a single cycle length method can be used to calculate aortic EOA in aortic stenosis with nonsinus rhythms is not known. Methods: Transthoracic echocardiograms of 100 patients with aortic stenosis and either atrial fibrillation (AF) or frequent ectopy (FE) were retrospectively reviewed. The aortic valve velocity time integral (VTIAV) and the left ven- tricular outflow tract VTI (VTILVOT) were measured by two methods: the standard method (averaging multiple beats) and the single cycle length method. The latter matches the R-R intervals for VTIAV and VTILVOT.Stroke volume, EOA, and Doppler velocity index were calculated by both methods in all patients. The single cycle length method was used for short and long R-R cycles in AF and for postectopic beats (long R-R cycles) in FE. Results: In AF, long R-R cycles resulted in larger stroke volumes (73 6 21 vs 63 6 18 mL; P # .0001) but no difference in EOA (0.84 6 0.27 vs 0.82 6 0.27 cm2; P = .11), whereas short R-R cycles resulted in smaller stroke volumes (55 6 18 vs 63 6 18 mL, P # .0001) but a larger EOA (0.86 6 0.28 vs 0.82 6 0.27 cm2; P = .01). -
Imaging and Impact of Myocardial Fibrosis in Aortic Stenosis
JACC: CARDIOVASCULAR IMAGING VOL. 12, NO. 2, 2019 ª 2019 THE AUTHORS. PUBLISHED BY ELSEVIER ON BEHALF OF THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION. THIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY LICENSE (http://creativecommons.org/licenses/by/4.0/). FOCUS ISSUE: IMAGING IN AORTIC STENOSIS: PART II STATE-OF-THE-ART PAPER Imaging and Impact of Myocardial Fibrosis in Aortic Stenosis a b a c Rong Bing, MBBS, BMEDSCI, João L. Cavalcante, MD, Russell J. Everett, MD, BSC, Marie-Annick Clavel, DVM, PHD, a a David E. Newby, DM, PHD, DSC, Marc R. Dweck, MD, PHD ABSTRACT Aortic stenosis is characterized both by progressive valve narrowing and the left ventricular remodeling response that ensues. The only effective treatment is aortic valve replacement, which is usually recommended in patients with severe stenosis and evidence of left ventricular decompensation. At present, left ventricular decompensation is most frequently identified by the development of typical symptoms or a marked reduction in left ventricular ejection fraction <50%. However, there is growing interest in using the assessment of myocardial fibrosis as an earlier and more objective marker of left ventricular decompensation, particularly in asymptomatic patients, where guidelines currently rely on non- randomized data and expert consensus. Myocardial fibrosis has major functional consequences, is the key pathological process driving left ventricular decompensation, and can be divided into 2 categories. Replacement fibrosis is irreversible and identified using late gadolinium enhancement on cardiac magnetic resonance, while diffuse fibrosis occurs earlier, is potentially reversible, and can be quantified with cardiac magnetic resonance T1 mapping techniques. There is a substantial body of observational data in this field, but there is now a need for randomized clinical trials of myocardial imaging in aortic stenosis to optimize patient management. -
Secundum Atrial Septal Defect Repair: Long-Term Surgical Outcome and the Problem of Late Mitral Regurgitation
Postgrad Med J (1993) 69, 912 - 915 D The Fellowship of Postgraduate Medicine, 1993 Postgrad Med J: first published as 10.1136/pgmj.69.818.912 on 1 December 1993. Downloaded from Secundum atrial septal defect repair: long-term surgical outcome and the problem oflate mitral regurgitation M.E. Speechly-Dick, R. John, W.B. Pugsley, M.F. Sturridge and R.H. Swanton Department ofCardiology, The Middlesex Hospital, Mortimer Street, London WIN 8AA, UK Summary: This study examines the clinical and surgical outcome of a group of 55 patients (mean age 33 years) with secundum atrial septal defect who underwent surgical repair ofthis defect between 1981 and 1990. A group of 25 of these patients underwent late echocardiographic follow-up. Fifty-two patients underwent repair by direct suturing and three by patch closure. Surgical mortality was nil. There was one late death ofa 58 year old who died from cardiac failure 4 years after surgery. Late postoperative morbidity consisted of two patients; one, age 63 at the time of surgery, required mitral and tricuspid valve replacement 6 years later and one, age 77 at surgery, developed cardiac failure 3 years later. Atrial fibrillation persisted in the six patients who had the rhythm before surgery and developed postoperatively in two patients aged 54 and 58. Two patients aged 49 and 57 developed immediate postoperative sinus node dysfunction requiring permanent pacing. The mean age at surgery of those six patients who suffered cardiac morbidity was 60 years. The patients with preoperative angiographic evidence of mitral valve prolapse were significantly older (P<0.001) and had higher mean pulmonary artery pressures (P<0.001) than patients with normal valves. -
CARDIAC SYNCOPE in ATRIAL SEPTAL DEFECT by CORNELIO PAPP from the Cardiac Department of the London Chest Hospital Received March 1, 1957
Br Heart J: first published as 10.1136/hrt.20.1.9 on 1 January 1958. Downloaded from CARDIAC SYNCOPE IN ATRIAL SEPTAL DEFECT BY CORNELIO PAPP From the Cardiac Department of the London Chest Hospital Received March 1, 1957 Atrial septal defect (A.S.D.) in adults is often asymptomatic and may be a chance discovery on clinical examination or at mass radiography. Symptoms arise late in the course of the disease and are those commonly seen in other cardiac conditions with right heart failure. Cardiac syncope has not been described as a leading symptom of A.S.D. and must be regarded as a rarity. It may be accidental that within six months of each other two patients came under observation on account of syncope and both had A.S.D. One knew of a cardiac murmur he had since childhood; the other was unaware of any heart disease. 'At a time when surgical repair is becoming a routine procedure in A.S.D., any new symptom has an added interest. This and the different mechanism of syncope in the two cases, caused by coexistent arrhythmia in both, justifies this report. CASE 1. A man, aged 22, a fitter, had known of his cardiac murmur since childhood and was rejected on account of it from military service when aged 18. He never complained of any shortness of breath, http://heart.bmj.com/ and had been able to run for short distances and climb stairs. His effort tolerance thus has been good if not normal. In May 1955 he cycled hurriedly to work because he was late. -
Echocardiographic Evaluation of Valvular Stenosis Melissa R
ECHOCARDIOGRAPHIC EVALUATION OF VALVULAR STENOSIS MELISSA R. CUNDANGAN, MD, FPCP, FPCC, FPSE AORTIC STENOSIS AORTIC STENOSIS • Obstruction to LV outflow • Decrease in aortic valve area • Normal: 3.0 – 4.0 cm2 • Mild : 1.5-2.0 cm2 • Moderate : 1.0 – 1.5 cm2 • Severe: < 1.0 cm2 Valvular Hear Disease, Chapter 63, Braunwarld’s Heart Disease 10th Edition 2014 AORTIC STENOSIS Causes: • Congenital (unicuspal, bicuspal, quadricuspal) • Rheumatic • Calcific/ Degenerative EAE/ASE recommendations for Echocardiographic assessment of valve stenosis, European Journal of Echocardiography 2009 ECHO EVALUATION OF AORTIC STENOSIS A. Evaluate the anatomy of the AV RCC DIASTOLE NCC LCC SYSTOLE EAE/ASE recommendations for Echocardiographic assessment of valve stenosis, European Journal of Echocardiography 2009 ECHO EVALUATION OF AORTIC STENOSIS fusion of RCC fusion of RCC and NCC and LCC ECHO EVALUATION OF AORTIC STENOSIS ECHO EVALUATION OF AORTIC STENOSIS ECHO EVALUATION OF AORTIC STENOSIS ECHO EVALUATION OF AORTIC STENOSIS B. Determine the aortic valve area by Continuity Equation EAE/ASE recommendations for Echocardiographic assessment of valve stenosis, European Journal of Echocardiography 2009 ECHO EVALUATION OF AORTIC STENOSIS C. Determine the transaortic jet velocity • measured using continuous-wave (CW) Doppler Valvular Hear Disease, Chapter 63, Braunwarld’s Heart Disease 10th Edition 2014 ECHO EVALUATION OF AORTIC STENOSIS D. Determine the transaortic gradient EAE/ASE recommendations for Echocardiographic assessment of valve stenosis, European Journal of Echocardiography 2009 ECHO EVALUATION OF AORTIC STENOSIS EAE/ASE recommendations for Echocardiographic assessment of valve stenosis, European Journal of Echocardiography 2009 • LOW FLOW LOW GRADIENT AORTIC STENOSIS • PARADOXICAL LOW FLOW LOW GRADIENT AORTIC STENOSIS Baseline echo AVA: 0.96 cm2 PIG: 57mmHg MG: 38 mmHg EF 31% PSEUDOSEVERE AORTIC STENOSIS .